| Literature DB >> 31187410 |
K Haraldstad1, A Wahl2, R Andenæs3, J R Andersen4, M H Andersen2, E Beisland4, C R Borge2, E Engebretsen2, M Eisemann5, L Halvorsrud3, T A Hanssen5,6, A Haugstvedt4, T Haugland7, V A Johansen4, M H Larsen2, L Løvereide8, B Løyland3, L G Kvarme3, P Moons9, T M Norekvål10, L Ribu3, G E Rohde11,12, K H Urstad8, S Helseth11,3.
Abstract
PURPOSE: Quality of life (QOL) is an important concept in the field of health and medicine. QOL is a complex concept that is interpreted and defined differently within and between disciplines, including the fields of health and medicine. The aims of this study were to systematically review the literature on QOL in medicine and health research and to describe the country of origin, target groups, instruments, design, and conceptual issues.Entities:
Keywords: Health-related quality of life; Quality of life; Systematic review
Mesh:
Year: 2019 PMID: 31187410 PMCID: PMC6761255 DOI: 10.1007/s11136-019-02214-9
Source DB: PubMed Journal: Qual Life Res ISSN: 0962-9343 Impact factor: 4.147
Fig. 1Flow chart of inclusion.
Source: Reproduced From Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta- Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. 10.1371/journal.pmed1000097. For more information, visit https://www.prisma-statement.org.
Evaluation of methodological and conceptual rigor according to the criteria from Gill and Feinstein (N = 163)
| Criteria |
| % |
|---|---|---|
| 1. Did the investigator give a definition of quality of life? | 22 | 13 |
| 2. Did the investigators state the domains they will measure as components of quality of life? | 57 | 34 |
| 3. Did the investigators give reasons for choosing the instrument they used? | 41 | 25 |
| 4. Did the investigator aggregate results from multiple items, domains or instruments into a single composite score for quality of life? | 88 | 53 |
| 5. Were patients asked to give their own global rating for quality of life? | 16 | 9 |
| 6. Was overall quality of life distinguished from health-related quality of life? | 11 | 6 |
| 7. Were the patients invited to supplement the items listed in the instruments offered by the investigators that they considered relevant for their quality of life? | 0 | |
| 8. If so, were these supplemental items incorporated into the final rating? | 0 | |
| 9. Were patients allowed to indicate which items were personally important to them? | 1 | 0.6 |
| 10. If so, were the importance ratings incorporated into the final rating? | 0 |
Country where the study was conducted
| Europe | N |
|---|---|
| Netherlands | 9 |
| Germany | 8 |
| England, Spain, | 7,7 |
| Turkey, Italy, France | 5,5,5 |
| Slovenia | 3 |
| Portugal, Poland | 2,2 |
| Norway, Ireland, Switzerland, Denmark, Romania, Belgium, Croatia | 1,1,1,1,1,1,1 |
| North America | |
| USA | 43 |
| Canada | 4 |
| Asia | |
| China | 18 |
| Korea | 5 |
| India, Japan | 4, 4 |
| Iran, Indonesia, Pakistan, Taiwan | 3,2,2 |
| Singapore, Israel, Taiwan | 1,1,1 |
| Oceania | |
| Australia | 7 |
| South America | |
| Brasil | 5 |
| Africa | |
| Uganda, Nigeria, South-Africa | 1,1,1 |
Study design
| Design | |
|---|---|
| RCT/experimental | 61 (37.6) |
| Cross-sectional/descriptive | 50 (31.6) |
| Cohort/prospective/longitudinal | 37 (22.1) |
| Methodological | 7 (4.1) |
| Case–control | 6 (3.6) |
| Mixed methods | 1 (0.6) |
| Qualitative | 1 (0.6) |
Number of studies related to patient groups, N = 163
| Patient groups | Adults | Children | Total |
|---|---|---|---|
| Cancer | 32 | 2 | 34 |
| Mental illness | 11 | 1 | 12 |
| Heart disease | 11 | – | 11 |
| Gastrointestinal disease | 10 | 1 | 11 |
| Kidney/renal | 9 | 1 | 10 |
| Community sample/normal population | 6 | 1 | 7 |
| Chronic obstructive pulmonary disease/asthma | 7 | – | 7 |
| Orthopedic | 6 | 2 | 7 |
| Elderly | 7 | – | 7 |
| Hemophilia | 4 | 1 | 5 |
| Gynecological disease | 4 | – | 4 |
| Obesity | 3 | 2 | 5 |
| Pain | 4 | – | 4 |
| Epilepsy/cerebral paresis | 2 | 2 | 4 |
| Multiple sclerosis | 4 | – | 4 |
| Diabetes | 2 | 1 | 3 |
| Psoriasis | 3 | – | 3 |
| Developmental problems | – | 2 | 2 |
| Allergy | 2 | ||
| Cystic fibrosis | 1 | 1 | 2 |
| Eye disease | 2 | 2 | |
| Fibromyalgia | 2 | 2 | |
| Cosmetics | 2 | – | 2 |
| Tinnitus, oral health, trans gender, hearing loss, HIV, myositis, nasal septum, brain injury, eating disorder | 1,1,1,1,1,1 1,1,1,1 | 10 | |
| Cleft lip | 1 | 1 | |
| Myelomeningocele | 1 | 1 | |
| Preterm | 1 | 1 |
Quality of life instruments used (N = 163)
| Instruments | Number of studies |
|---|---|
| Generic | |
| Short form SF-36 | 21 |
| EQ-5D | 16 |
| WHOQOL-BREF | 7 |
| Short form SF-12 | 5 |
| Cantrills ladder | 2 |
| Satisfaction with Life Scale (SWLS) | 2 |
| Disease specific | |
| EORTC QLQ C-30 | 15 |
| Gastrointestinal QOL index (GIQLI) | 4 |
| Asthma Quality of Life Questionnaire (AQLQ) | 3 |
| Dermatology Life Quality score, (DLQI) | 3 |
| Stroke Specific QOL Scale | 2 |
| McGill QOL Questionnaire | 2 |
| The Haemo-QOL Questionnaire | 2 |
| Patient outcome measurement information system (PROMIS) | 2 |
| FACT-L | 2 |
| National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25) | 1 |
| Sexual Function Questionnaire-12 (PISQ-12) | 1 |
| DLQ1 | 1 |
| QLESQ-SF | 1 |
| Melasma QOL questionnaire | 1 |
| Owestry dis index (ODI) | 1 |
| Inflam. Bowel Disease Questionnaire (IBDQ) | 1 |
| MG-QOL 15 | 1 |
| NOSE nasal obstruction symptom evaluation | 1 |
| The ten-item Lehman’s quality of life (QOL) measure | 1 |
| Celiac dietary, CD quality of life | 1 |
| Epilepsy and Learning Disabilities Quality of Life Scale (ELDQOL) | 1 |
| Nutri- QOL | 1 |
| The Hand-Foot Skin Reaction QOL Questionnaire (HF-QOL-K) | 1 |
| Food Allergy Quality of Life Parental Burden | 1 |
| Seattle Angina Questionnaire (SAQ-QOL) | 1 |
| FertiQOL | 1 |
| QOL Alzheimer’s Disease Scale | 1 |
| Patient Health Questionnaire-2 score (PHQ2) | 1 |
| Incontinence Impact Questionnaire Short Form (31Q, IIQ-7) | 1 |
| Glaucoma-specific preference-based HRQOL instrument | 1 |
| CAS 20 | 1 |
| CASP-12 | 1 |
| Dartmount coopertive functional assessment charts (COOP) | 1 |
| Stoma-QOL Questionnaire | 1 |
| Kansas City Cardiomyopathy Questionnaire (KCCQ) | 1 |
| Children | |
| Generic | |
| PedsQl | 5 |
| Child Health Questionnaire (CHQ) | 2 |
| KINDL | 2 |
| KIDSCREEN 27 | 1 |
| DISABKIDS HRQOL | 1 |
| Preschool Children’s Quality of Life Questionnaire (TAPQOL) | 1 |
| Disease specific | |
| PedsFact-BrS | 1 |
| Questionnaire QOL fécal Continence in Children (QQVCFCA) | 1 |
| Child oral health impact profile-(COHIP) | 1 |
| Cystic Fibrosis QOL Questionnaire-Revised | 1 |